Unlocking the potential of
genomic medicine


Aevi Genomic Medicine is focused on translating genetic discoveries into novel therapies to improve the lives of children and adults with pediatric onset life altering diseases.  More>>

There are no items to display.

Stock Quote

Recent News

More >>
Date Title and Summary
Toggle Summary03/20/2018
PHILADELPHIA , March 20, 2018 /PRNewswire/ --  Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today that Michael F. Cola , President and Chief Executive Officer, will present at the 17th Annual Needham Healthcare Conference at 8:30 AM EDT on Wednesday, March 28, 2018 at the
Toggle Summary03/13/2018
PHILADELPHIA , March 13, 2018 /PRNewswire/ --  Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) (the Company) announced today financial and operational results for the three and twelve months ended December 31, 2017 . Fourth Quarter and Year-End Corporate Highlights Continued advancing and strengthening
Toggle Summary03/07/2018
-Early stage program in an ultra-orphan pediatric indication with potential to expand to additional indications post proof of concept. PHILADELPHIA , March 7, 2018 /PRNewswire/ --  Aevi Genomic Medicine, Inc. (NASDAQ MKT: GNMX) today announced that it has expanded its collaboration with Kyowa Hakko

Recent Presentations

More >>

Upcoming Events

More >>
There are currently no events to display.

Receive E-mail Alerts

Sign up to receive e-mail alerts whenever Aevi Genomic Medicine, Inc. posts new information to the site. Just enter your e-mail address and click Submit.

Copyright Nasdaq. Minimum 15 minutes delayed.